Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Warnock

Showing results (291-300 of 371) with videos related to

Pageof 38
Sort By:
Journal of Medical Genetics|September 15, 2019
Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry diseaseIvan D Doykov, Wendy E Heywood, Valeria Nikolaenko, et al.
The American Journal of Physiology|January 1, 1996
Peptide block of constitutively activated Na+ channels in Liddle's diseaseI I Ismailov, B K Berdiev, C M Fuller, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2012
Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participantsDeidra C Crews, William M McClellan, David A Shoham, et al.
Kidney International|December 18, 2014
Obesity, metabolic health, and the risk of end-stage renal diseaseBhupesh Panwar, Lynae J Hanks, Rikki M Tanner, et al.
Journal of Medical Genetics|October 23, 2015
Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapyDavid G Warnock, Christie P Thomas, Bojan Vujkovac, et al.
International Journal of Health Geographics|March 23, 2013
Association of duration of residence in the southeastern United States with chronic kidney disease may differ by race: the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort studyLaura Plantinga, Virginia J Howard, Suzanne Judd, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 15, 2011
Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRDWilliam M McClellan, David G Warnock, Suzanne Judd, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 23, 2009
End-stage renal disease in patients with Fabry disease: natural history data from the Fabry RegistryAlberto Ortiz, Bruno Cianciaruso, Marta Cizmarik, et al.
American Journal of Epidemiology|December 11, 2008
Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary StudyNeil A Zakai, Leslie A McClure, Ronald Prineas, et al.
Contributions to Nephrology|June 2, 2012
Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysisDavid G Warnock, Sudarshan Hebbar, Joanne Bargman, et al.
Pageof 38

Showing results (291-300 of 371) with videos related to

Sort By:
Pageof 38
Journal of Medical Genetics|September 15, 2019
Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry diseaseIvan D Doykov, Wendy E Heywood, Valeria Nikolaenko, et al.
The American Journal of Physiology|January 1, 1996
Peptide block of constitutively activated Na+ channels in Liddle's diseaseI I Ismailov, B K Berdiev, C M Fuller, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2012
Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participantsDeidra C Crews, William M McClellan, David A Shoham, et al.
Kidney International|December 18, 2014
Obesity, metabolic health, and the risk of end-stage renal diseaseBhupesh Panwar, Lynae J Hanks, Rikki M Tanner, et al.
Journal of Medical Genetics|October 23, 2015
Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapyDavid G Warnock, Christie P Thomas, Bojan Vujkovac, et al.
International Journal of Health Geographics|March 23, 2013
Association of duration of residence in the southeastern United States with chronic kidney disease may differ by race: the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort studyLaura Plantinga, Virginia J Howard, Suzanne Judd, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 15, 2011
Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRDWilliam M McClellan, David G Warnock, Suzanne Judd, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 23, 2009
End-stage renal disease in patients with Fabry disease: natural history data from the Fabry RegistryAlberto Ortiz, Bruno Cianciaruso, Marta Cizmarik, et al.
American Journal of Epidemiology|December 11, 2008
Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary StudyNeil A Zakai, Leslie A McClure, Ronald Prineas, et al.
Contributions to Nephrology|June 2, 2012
Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysisDavid G Warnock, Sudarshan Hebbar, Joanne Bargman, et al.
Pageof 38